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The polymerase chain reaction was used to randomly
mutagenize a cDNA cassette encoding amino acids 691–
946 of the sheep Na,K-ATPase a subunit. The mu-
tagenized cassettes were used to replace the wild-type
region in the full-length cDNA, and pools of mutants
were transfected into HeLa cells. After the generation of
resistant cells via selection in 0.5 mM ouabain, polymer-
ase chain reaction was used to amplify the mutagenized
cassette from the genomic DNA of the stable transfec-
tants. Sequence analysis of the polymerase chain reac-
tion product revealed three amino acid substitutions:
I729V, L793P, and K836R. Subsequent site-directed mu-
tagenesis experiments showed that only L793P was im-
portant for resistance. To elucidate the role of L793 in
ouabain inhibition, additional mutations at this position
were prepared. L793A and L793I mutants were con-
structed and expressed in HeLa cells. Only L793A sur-
vived selection using ouabain, which suggested that re-
sistance is not due to the specific substitution of leucine
with proline. To explore the mechanism of resistance,
apparent affinities of the L793P mutant for sodium and
potassium were compared to the wild-type HeLa pump.
Although the apparent affinities were comparable for
sodium, themutant had a 2-fold higher apparent affinity
for potassium. This suggests that the mechanism of oua-
bain insensitivity of L793P is due to a perturbation in
the region of the enzyme that may include the K1 bind-
ing site.
Na,K-ATPase is located on the cell membrane of all eukary-
otic cells and maintains the electrochemical gradient of the cell.
It consists of a larger a subunit and a smaller, glycosylated b
subunit. The former is the catalytic subunit; it pumps three
Na1 ions out in exchange for two K1 ions pumped into the cell
at the expense of ATP. It is also the site of interaction with
cardiac glycosides, compounds that are commonly used to treat
congestive heart failure. There is considerable interest in the
characterization of the ouabain binding site of Na,K-ATPase to
better understand the ouabain binding site with the aim of
promoting rational drug design.
The site of cardiac glycoside binding is not fully understood,
in part because the three-dimensional structure of the enzyme
has not been elucidated. The amino-terminal half of the protein
was found to be important after a chimera comprising the
amino-terminal half of the ouabain-resistant rat a1 enzyme
and the carboxyl-terminal half of the ouabain-sensitive sheep
a1 enzyme proved to be ouabain resistant (1). Subsequently,
several amino acids in the amino-terminal half of the protein
were identified that affected inhibition of the enzyme by oua-
bain. Using the numbering of Shull et al. (2), these include the
cysteine and tyrosine in the first transmembrane domain; Cys-
104 (3, 4) and Tyr-108 (4); Gln-111 (1, 2), Pro-118 (4), Asp-121
(5), and Asn-122 (1, 6) in the first extracellular domain; and
Tyr-308, located in the extracellular domain between the pu-
tative H3-H4 transmembrane domains (7).
The possibility that the carboxyl half of the protein may
interact with ouabain was initially suggested by the finding
that a monoclonal antibody localized to the H1-H2 extracellu-
lar domain increased ouabain binding (8). Furthermore, a chi-
mera that was made using the amino-terminal half of the
H,K-ATPase and the carboxyl-terminal half of the rat a1 Na,K-
ATPase retained sensitivity to ouabain (9). Soon thereafter,
Thr-797 (10–12) and Arg-880 (4) were identified as being im-
portant in conferring sensitivity to ouabain.
Based on the hypothesis that the carboxyl-terminal half of
this protein, like the amino-terminal half, potentially has sev-
eral residues that affect the interaction with ouabain, we have
reexamined a region of the sheep a1 subunit that includes
amino acids 691–946 using PCR1-based random mutagenesis.
This region encompasses a cytoplasmic region, the putative
transmembrane domains H5 and H6, and two large predicted
extracellular domains.
EXPERIMENTAL PROCEDURES
Materials—Molecular biology reagents were from Amersham Corp.,
Boehringer Mannheim, Pharmacia Biotech Inc., Promega, QIAGEN
Inc., Stratagene, and U. S. Biochemical Corp. Reagents used in enzyme
assays were obtained from Aldrich, and National Diagnostics (Atlanta,
GA). Tris-ATP was from Sigma, g-[32P]ATP from DuPont NEN, and
ouabain from Boehringer Mannheim. Bio-Rad was the source for elec-
troporation equipment. Tissue culture supplies were obtained from Life
Technologies, Inc., and the Lineberger Cancer Center Tissue Culture
Facility at the University of North Carolina. All other reagents were of
the highest quality available. The eukaryotic expression vector con-
structs were described previously (1). The vector, pKC4, has the com-
plete cDNA inserts of either sheep a1 (Sa1-pKC4) or rat a1 (rat a1-
pKC4) Na,K-ATPase subunits. The sheep a1 cDNA is divided by
endonuclease restriction sites into discrete cassettes that are compati-
ble with the M13 multiple cloning site.
Random Mutagenesis—PCR-based random mutagenesis, based on a
protocol by Leung et al. (13), is outlined in Fig. 1. The most salient
features are that the reactions were conducting using a 1.0 mM concen-
tration of each of the four deoxynucleotide triphosphates except for
dATP, which was at a concentration of 0.2 mM. Furthermore, 0.5 mM
MnCl2 was added so that, with MgCl2, the total ion concentration was
6.0 mM. Under these conditions, the fidelity of the Taq DNA polymerase
is compromised. It was estimated that the error rate increased from
0.4% under normal conditions to approximately 2% in the altered con-
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ditions. The reaction template was the eukaryotic expression vector
pKC4 containing the sheep a1 cDNA. The vector was linearized using a
unique Sca I site, which cuts outside of the sheep coding sequence. Two
oligonucleotide primers were designed to amplify a region that includes
the restriction enzyme sites HindIII and BglII, which define a region of
the cDNA corresponding to amino acids 691–946 in the sheep a1 sub-
unit. The forward primer was 59-AAGTACCACACGGAGATTGT-
GTTC-39 and the reverse primer was 59-GAAAGCAGCAAGGGCT-
GTCTCTTC-39. The negative control was deionized distilled water.
Both primers were used at a concentration of 20 pmol per 100 ml of
reaction volume. Amplification was performed on an Eri-Comp Twin-
Bloc thermal cycler and consisted of an initial denaturation (94 °C for 6
min) after which Taq polymerase was added, followed by 30 cycles of
annealing (50 °C for 1 min), elongation (70 °C for 4 min), and denatur-
ation (94 °C for 1 min), followed by 2 min at 55 °C, and finally, holding
at 72 °C for 10 min. The PCR product was size-fractionated by electro-
phoresis on a 1% agarose gel, then excised and gel purified with the
Qiaex gel extraction kit (QIAGEN). The purified PCR fragment (;780
base pairs) was digested withHindIII and BglII, and the pool of mutant
cassettes was used to replace the wild-type cassette in the expression
vector Sa1-pKC4 that had likewise been digested with HindIII and
BglII.
Site-directed Mutagenesis—Mutagenesis of the HindIII/BglII cas-
sette was performed as described previously (1) and according to the
method of Kunkel (14). Several oligonucleotides were designed to re-
produce the changes found in the original resistant mutant when an-
nealed to single-stranded M13 containing the cassette. The base at
2464, according to the numbering of Shull et al. (2), was changed from
A to G; likewise, base 2657 was changed from T to C and base 2786 from
A to G. Several plaques from each mutagenesis experiment were picked
and sequenced. Those cassettes with the mutation were sequenced in
their entirety. Double-stranded (replicative form) form of the mutant
cassette in M13 was double digested withHindIII and BglII and ligated
back into the Sa1-pKC4 that had also been double digested. DH5aF9
cells were transformed and several colonies were screened using restric-
tion endonuclease digests. Positive colonies had the 763-bp cassette
sequenced in its entirety before the construct was purified on a cesium
chloride gradient in preparation for electroporation into wild-type HeLa
cells.
Cell Culture and Transfection—HeLa cells were grown in Dulbecco’s
modified Eagle’s medium supplemented with 10% bovine calf serum
and antibiotics. Cells were prepared for transfection as described pre-
viously by Burns and Price (10). Each electroporation combined 20 mg of
linearized plasmid with 1 3 106 HeLa cells. Electroporation of the
randomly mutagenized plasmid used a total of 1 mg of pooled mutant
plasmid that was transfected into a total of 5 3 107 cells in 50 separate
electroporations. Each electroporation was plated to a 100-mm tissue
culture plate. Cells that were resistant to ouabain were isolated using
a cloning cylinder. These cell lines were expanded in medium contain-
ing 0.5 mM ouabain.
RNA Analysis—Analysis of all ouabain-resistant cell lines used the
protocol described by Price and Lingrel (1).
Recovery of Mutagenized Cassettes from Stably Transfected Ouabain-
resistant Cell Lines and Sequencing—Genomic DNA was prepared for
amplification as described previously (10) and was essentially as de-
scribed by Higuchi (15). The two oligonucleotide primers were the same
as those used to amplify the cassette for random mutagenesis. The PCR
reactions were essentially the same as above, except that the dNTPs
were used in equimolar concentrations and no MnCl2 was added to the
reaction. PCR products were gel purified with the Qiaex gel extraction
kit (QIAGEN) and sequenced directly by adapting the methods of Kretz
et al. (16) and Kusukawa et al. (17) to more readily accommodate the
annealing reaction as outlined in the Sequenase 2.0 kit from U. S.
Biochemical Corp. The primer:template ratio was set at approximately
100:1. After the addition of annealing buffer and deionized distilled
water, the total volume was 10 ml. This was incubated at 95 °C for 2
min, then put on ice immediately. Sequencing followed, according to the
instructions in the Sequenase 2.0 kit, which is based on the method of
Sanger et al. (18). To control for the possibility of errors introduced by
Taq DNA polymerase, PCR products from eight separate reactions
based on the original resistant cell line were pooled. Sequence of site-
directed mutants was based on a pool of five separate PCR reactions.
Preparation of Crude Plasma Membranes from HeLa Cells—Mem-
branes were prepared from wild-type HeLa cells and cells transfected
with Lys-mutants or rat a1. This was done essentially as described by
Price and Lingrel (1), except that cells from five confluent T150 flasks
were harvested and cells were homogenized using 30–40 strokes of a
Dounce-type homogenizer, and the final preparation was suspended in
FIG. 1. Random mutagenesis flow chart. This figure outlines the major steps taken to produce the original resistant mutant RMPCR-1.
Details of primers used, PCR protocols, and transfection can be found under “Experimental Procedures.”
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1 mM Tris and 1 mM EDTA, pH 7.4. Protein yields were determined (19)
using bovine serum albumin as the standard. Microsome preparations
were snap frozen in liquid nitrogen, stored at 270 °C, and used within
3 months.
Na,K-ATPase Activity Assay and Data Analysis—Enzyme activity
was determined by the release of g-32P from g-[32P]ATP in an assay that
was essentially as described by Jewell and Lingrel (20) in a method
modified from Brown (21). In brief, assays were prepared in 1.7-ml
tubes, split into triplicates, and incubated at 37 °C for 1 h. Tubes were
placed on ice, and 250 ml of acid molybdate (5% ammonium molybdate
in 2 N H2SO4 containing 9.17% trichloroacetic acid and 2 mM phosphate
that was diluted 2:3 with H2O) and 800 ml of a 1:1 mix of isobutanol:
ethyl acetate were added. Tubes were shaken for 15 s three times at
intervals of 5 min and centrifuged briefly; then 500 ml of organic phase
was transferred to 5 ml of scintillation fluid. Counts were taken to give
an error of 61%. Less than 20% of the ATP was hydrolyzed over the
course of 1 h in any tube. Release of phosphate over the hour was linear
in all assays.
Na,K-ATPase activity was determined against increasing concentra-
tions of ouabain, NaCl, and KCl. In ouabain sensitivity experiments,
specific enzyme activity was taken as the difference between the activ-
ity at 1022 M ouabain and the test concentrations of ouabain. Activity in
ouabain-free mediumwas taken as 100% activity. The rate of phosphate
release was linear at each concentration of ouabain. The specific con-
ditions for the ouabain experiments were as detailed by Jewell and
Lingrel (20). All experimental data were analyzed for goodness of fit to
either a one-site or two-site Michaelis-Menten equation for microsome
preparations expressing mutant enzyme, as well as those from the host
cell line (22). Cell lines expressing mutants fit best to the two-site
model, so the lower affinity site was taken as the IC50 for the mutant
enzyme. The higher affinity site was within the standard error for the
IC50 of wild-type HeLa cells using the one-site model.
In the ion dependence experiments, specific Na,K-ATPase activity
was taken as the difference between activity in ion-free medium and the
test concentrations of ion. ATPases that were non-Na,K-ATPases were
not dependent on ion concentration. When preparations containing
mutant enzyme were assayed, 1 mM ouabain was in the assay medium
to inhibit the native ouabain-sensitive pump of HeLa cells. The specific
conditions for the ion dependence experiments were as detailed by
Jewell and Lingrel (20). In these experiments, 100% activity was activ-
ity at Vmax according to the equation,
v 5 Vmax/~1 1 EC50(ion)/[ion])n (Eq. 1)
where n 5 3 for Na1 and n 5 2 for K1; this equation assumes that each
ion binding site is independent. Data were also fit to the equation,
v 5 Vmax@ion#n/~EC50(ion) 1 @ion#n! with EC50 5 EC50(ion)1/n (Eq. 2)
where n 5 3 for Na1 and n 5 2 for K1; this equation does not assume
independence between ion binding sites. Both equations are from Garay
and Garrahan (23). These models were fit using nonlinear regression
with SigmaPlot (Jandel Scientific), which fits by minimizing the sum of
squares of differences between data and model.
RESULTS
The pool of mutated cDNAs resulted in one resistant clone
from a total of 50 tissue culture dishes when transfected cells
were selected in 0.5 mM ouabain. This clone, designated RM-
PCR1 was expanded into a stable cell line and maintained in
0.5 mM ouabain. Genomic DNA was isolated from these cells
and PCR was used to amplify the integrated, randomly mu-
tated cassette. The amplicon was of the expected size based on
the cDNA (;780 base pairs; data not shown). Product from
endogenous Na,K-ATPase gene of the HeLa genome would be
expected to be significantly larger because introns would be
included in the PCR product. Northern analysis using a probe
targeted to a region coding for the small t intron of the SV40
vector that is inserted between the cDNA and the polyadenyl-
ation sequence indicated that the original resistant clone ex-
pressed this vector-derived RNA (data not shown). The PCR
product recovered from RMPCR1 genomic DNA is therefore
probably the result of stable integration of the randomly mu-
tagenized vector into the HeLa genome. The resistant pheno-
type is likely due to the presence and expression of the mutant
sheep a1 cDNA.
Sequencing revealed that RMPCR1 contains a sheep-specific
sequence with four base pair changes that code for three amino
acid changes. Using the numbering of Shull et al. (2), the base
at 2464 was changed from A to G, producing the amino acid
change I729V; base 2541 was changed from A to G but did not
change the code for glycine; base 2657 was changed from T to C,
producing L793P; and base 2786 was changed from A to G,
which produced K836R. According to a predicted two-dimen-
sional structure based, again, on Shull et al. (2), I729V is
predicted to be intracellular, L793P lies in the putative fifth
transmembrane domain, and K836R is predicted to be
extracellular.
After identification of the mutated base, site-directed mu-
tagenesis was used to reproduce pairs of mutations in the
wild-type sheep a1 cDNA (Table I). Because the three-dimen-
sional structure of this enzyme is not known, it was possible
that resistance to ouabain was due to any individual change or
to the combined conformational effects of any two or all three
amino acids. To discriminate the contribution of each mutation
or combination to resistance, pairs of mutations were made and
expressed in HeLa cells. Depending on what pair(s) survived,
the individual or combination of important amino acid(s) could
be deduced. The L793P mutant was constructed individually
because it was the least conservative change of the three and
therefore was thought the most likely candidate for causing
resistance. Results from transfections (Table I) show that only
when L793P was in the construct (i.e. either the double mu-
tants I729V/L793P and L793P/K836R or the single mutant
L793P) were the cells resistant to ouabain. These data indicate
that the single mutant L793P was solely responsible for the
ouabain-resistant character of the original resistant HeLa
cells. Two clones from the transfection experiment with the
individual mutant L793P were isolated and expanded into sta-
ble cell lines designated L793P1 and L793P2. Northern analy-
sis on these cell lines was positive for the vector-derived se-
TABLE I
Number of resistant colonies after transfection of mutant sheep a1 cDNAs into HeLa cells and selection in 0.5 mM ouabain
Constructa
Experiment 1 Experiment 2
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3
None 0 0 0 0 —b —
Sheep a1 0 0 0 0 — —
Rat a1 11 24 20 71 — —
I729V 1 L793P 16 28 25 — — —
I729V 1 K836R 0 0 0 — — —
L793P 1 K836R 12 14 16 — — —
L793P 31 16 27 — — —
L793I — — — 0 0 0
L793A — — — 3 5 6
a Construction of sheep a1 NaK-ATPase mutants is described under “Experimental Procedures.” Each transfection used 20 mg of linearized
plasmid and 1 3 106 HeLa cells.
b —, not performed.
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quence described above (data not shown). Furthermore,
sequencing of PCR product derived from genomic DNA verified
that the cDNA that was integrated into the genomic DNA of the
host cell contained the site-directed L793P change.
Crude membranes from the two L793P cell lines, as well as
from wild-type HeLa cells, and a stable cell line expressing rat
a1 were prepared and assayed for the ability of ouabain to
inhibit Na,K-ATPase activity (Fig. 2). The L793P1 and L793P2
cell lines are comparable in their resistance to ouabain, which
approaches that of the cell line expressing the rat a1 subunit
(Fig. 2, inset).
These mutant Na,K-ATPases were also characterized for
their dependence on Na1 and K1 ions for activity (Table II) and
were compared to wild-type HeLa Na,K-ATPase. These data
show that little difference in the dependence of Na1 exists
between the L793P mutants and the wild-type enzyme,
whereas significant differences are seen in the dependence on
K1 on activity. The measured dependence on K1 suggests that
the mutant ouabain-resistant enzymes have a higher affinity
for K1 than does the wild-type enzyme. Data were fit to both
independent and cooperative models, but there was no differ-
ence in conclusions derived from these models.
To test the hypothesis that the mechanism of resistance
introduced by this substitution is due to a localized change in
conformation that may be specific to substitution with proline,
two other amino acids with nonpolar side chains were substi-
tuted: isoleucine to maintain the size and polarity of leucine,
and alanine, to vary the size. As with all site-directed mutants,
the mutagenized cassette was sequenced in its entirety before
being transfected into the host cells. Table I indicates that
resistance of the Leu-793 substitution is not specific to proline
substitution, because L793A generated ouabain-resistant colo-
nies. The identities of the L793A clones were verified, as de-
scribed previously, by collecting genomic DNA from three
clonal cell lines, using PCR to amplify the pertinent cassette,
and sequencing the PCR product. All three cell lines produced
the correct size of amplicon, and sequence analysis revealed a
sheep-specific sequence that contained the engineered base
changes.
DISCUSSION
There were three amino acid changes produced using this
PCR-based random mutagenesis method. Interestingly, each
amino acid is conserved in all Na,K-ATPases reported to date
(24). However, L793P accounted for most if not all of the re-
sistance of the original triple mutant. This was supported by
the fact that the IC50 values for the L793P stable cell lines were
comparable to the IC50 for rat a1 construct, a sodium pump
that is highly resistant to ouabain (20) (Fig. 2). Although nei-
ther the I729V nor the K836R mutations could confer resist-
ance to ouabain, this does not exclude these residues from
contributing to ouabain sensitivity, as might have been seen if
less conservative substitutions had occurred at these sites.
One possible mechanism of resistance could have been an
increase in affinity for both ions, resulting in a more efficient
enzyme. Because enzyme activities in response to increasing
concentrations of sodium were not significantly different be-
tween the mutant and the host cell, any increase in the effi-
ciency of this enzyme with regard to Na1 is probably negligible.
Alternatively, the conformational change that accompanies the
catalytic cycle may occur more readily, even in the presence of
ouabain. Activity in response to an increasing concentration of
potassium showed that the mutant pump could achieve com-
parable rates of activity at half the concentration of potassium
when compared to the host cell response, suggesting that the
affinity for potassium is increased in the L793P mutant. John-
son et al. (25) have shown that an increase in K1 concentra-
tions correlates with decreased ouabain binding in the sheep
Na,K-ATPase. It is possible that increased affinity for K1
causes increased competition with ouabain at the ouabain
binding site, and this may be the mechanism of resistance in
the L793P mutant. Although K1 and ouabain binding sites are
not thought to be identical (25), leucine 793 may be a residue
that these two sites share.
The L793P inserts a proline between two other prolines in a
region that is predicted to be a transmembrane domain (2).
Because a polyproline sequence forms a left-handed helix with
three prolines per turn, it is expected that the local conforma-
FIG. 2. Na,K-ATPase activity inhibited by ouabain. The inset
table shows the IC50 mean 6 S.E. from the respective cell lines. Each
mean was derived from three experiments, each done in triplicate.
Membranes were prepared from wild-type HeLa cells and clones were
transfected with site-directed mutants, as described under “Experimen-
tal Procedures.” All values were corrected for background activity meas-
ured in 1022 M ouabain. Percent activity was determined by setting the
activity in the ouabain-free assay to 100%. l, wild type (wt) HeLa; f,
rat a1; å, L793P-1; ç, L793P-2. The specific Na,K-ATPase activity
(mmol of ATP hydrolyzed per mg of protein/h) of each microsome prep-
aration without ouabain was: wild type HeLa 5 33.9 1 0.54; rat a1 5
29.35 1 0.73; L793P1 5 11.63 1 0.13; and L793P2 5 27.55 1 0.60. Plots
for mutants are representative of three assays from at least two sepa-
rate microsome preparations. Solid lines indicate data fit to the one-site
Michaelis-Menten equation; dashed lines indicate data fit to the two-
site equation.
TABLE II
Dependence of NaK-ATPase activity on increasing concentrations of
Na1 and K1 ions
EC50 values represent means 6 S.E. Each experiment was performed
in triplicate. For details, see “Experimental Procedures.”
Ion
EC50
L793P-1 L793P-2 Wt HeLa
mM
Na1a 2.82 6 0.21 2.67 6 0.12 2.09 6 0.21
(0.25)b (0.17) (0.16)
K1a 0.37 6 0.04 0.46 6 0.12 0.94 6 0.13
(0.03) (0.07) (0.13)
Na1c 8.20 6 0.30 6.34 6 0.08 5.17 6 0.03
(0.49) (0.21) 0.20)
K1c 0.72 6 0.03 0.79 6 0.02 1.43 6 0.18
(0.18) (0.23) (0.30)
a Data fit to the noncooperative model: v 5 Vmax/(1 1 EC50(ion)/[ion]
n.
n 5 3 for Na1; n 5 2 for K1.
b Numbers in brackets represent the mean of the standard deviation
corresponding to the fit of the data for each particular model. Generated
using SigmaPlot by s 5 (CV%/100)(K0.5).
c Data fit to the cooperative model: v 5 Vmax[ion]
n/EC50(ion) 1 [ion]
n)
with EC50 5 EC50(ion)
1/n, n 5 3 for Na1; nb 5 2 for K1.
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tion of the protein will be disrupted regardless of the original
conformation. However, because the host HeLa cells cannot
survive in 0.5 mM ouabain, the L793P mutant must be a func-
tioning protein. To determine whether resistance was specific
to the L793P substitution, two conservative substitutions,
L793I and L793A, were constructed, expressed in HeLa cells,
and selected for their ability to resist inhibition by ouabain.
L793I is the most conservative change, so it was not expected
that this construct would survive. Because L793A did survive
(Table I), resistance is not isolated to any conformational
changes inherent to substitution with proline alone. It is diffi-
cult to predict what the effects of the alanine substitution may
have on this area. It is possible that resistance is due to con-
formational shifts in the protein that disrupt the relative posi-
tion of at least part of the fifth transmembrane domain so that
interactions between residues of juxtaposed transmembrane
domains may redefine either or both of the ouabain and K1
binding site.
In summary, leucine 793 has been identified as an amino
acid in the carboxyl-terminal half of the protein, which plays a
significant role in the interaction between ouabain and the
sodium pump. This residue resides in the putative fifth trans-
membrane domain and lies very close to threonine 797, an
additional residue recently shown to be involved in ouabain
inhibition (10–12). Therefore, this region is clearly important
for the interaction between ouabain and the Na,K-ATPase.
These findings also support the utility of PCR-based random
mutagenesis in the study of proteins, the tertiary structure of
which is not available.
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